107 Results for "

DOPA

" in MedChemExpress (MCE) Product Catalog:
Products (107)

107 Results for "DOPA" in MCE Product Catalog:

Cat. No.: HY-110286
CAS No.: 21373-30-8
Purity:  95.23%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

6-Hydroxy-DOPA is a selective and effective allosteric inhibitor of the RAD52 ssDNA binding domain. 6-Hydroxy-DOPA can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-113468
CAS No.: 7636-26-2
Purity:  99.94%
Synonyms: 3-Methoxytyrosine
3-O-Methyl-DL-DOPA is an endogenous metabolite present in Cerebrospinal_Fluid that can be used for the research of Epilepsy, Purine Nucleoside Phosphorylase Deficiency and Aromatic L Amino Acid Decarboxylase Deficiency .
loading...
    loading...
Cat. No.: HY-14561A
CAS No.: 79944-56-2
Purity:  99.32%
Synonyms: RX 781094 hydrochloride
Idazoxan hydrochloride (RX 781094 hydrochloride) is an α2-adrenoceptor antagonist and is also a imidazoline receptors (IRs) antagonist competitively antagonized the centrally induced hypotensive effect of imidazoline-like agents (IMs). Idazoxan hydrochloride also improves motor symptoms in Parkinson’s disease, L-DOPA-induced dyskinesias, and experimental Parkinsonism .
loading...
    loading...
Cat. No.: HY-N1750
CAS No.: 5631-68-5
3-(2,4-Dihydroxyphenyl) propanoic acid (DPPacid) is a competitive Tyrosinase inhibitor. It exhibits an IC50 value of 3.02 μM against mushroom tyrosinase with L-tyrosine as the substrate, an IC50 value of 62 μM with DL-DOPA as the substrate, and a Ki value of 11.5 μM. 3-(2,4-Dihydroxyphenyl) propanoic acid shows no DPPH radical scavenging activity. It can be used in studies related to ultraviolet B (UVB)-induced hyperpigmentation .
loading...
    loading...
Cat. No.: HY-113357
CAS No.: 588-30-7
Purity:  99.84%
m-Coumaric acid is a polyphenol metabolite from caffeic acid, formed by the gut microflora and the amount in human biofluids is diet-dependant. m-Coumaric acid is a BBB-penetrant metabolite of chlorogenic acid. m-Coumaric acid stimulates the cerebral nerves in vitro. m-Coumaric acid can evoke neurite outgrowth in hippocampal neuronal cells. m-Coumaric acid can promote neuronal differentiation. m-Coumaric acid increases spontaneous locomotor activity in mice by acting on the central nervous system. m-Coumaric acid inhibits the oxidation of L-dopa by epidermis tyrosinase. m-Coumaric acid attenuates non-catalytic protein glycosylation in retinas of diabetic rats .
loading...
    loading...
Cat. No.: HY-100705
CAS No.: 20357-25-9
Purity:  98.76%
Synonyms: 6-Nitroveratraldehyde
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

DMNB (6-Nitroveratraldehyde) is a photolabile proton donor that releases acidic substances when excited at a wavelength of 405 nM. DMNB can be used for the synthesis of no-carrier-added 6-[18F]fluoro-L-DOPA (6-FDOPA). DMNB is also applicable to the preparation of o-nitroaryl-bis (5-methylfur-2-yl) methanes and the synthesis of alpha-asarone (HY-N0700). DMNB is an enzyme involved in the non-homologous end joining (NHEJ) pathway responsible for DNA double-strand break (DSB) repair. DMNB can be used in PET studies of the dopaminergic system .
loading...
    loading...
Cat. No.: HY-B0927
CAS No.: 118-08-1
Synonyms: (-)-β-Hydrastine; (1R,9S)-β-Hydrastine
Hydrastine ((-)-β-Hydrastine; (1R,9S)-β-Hydrastine) is a selective competitive inhibitor of tyrosine hydroxylase (TH), inhibiting dopamine biosynthesis (IC50=20.7 μM, PC12 cells). Hydrastine also inhibits the organic cation transporter OCT1 (IC50=6.6 μM). Hydrastine may cause neuronal toxicity through mitochondrial dysfunction rather than oxidative stress damage, and can aggravate cell apoptosis when combined with L-DOPA. Hydrastine can be used to study Parkinson's disease-related dopaminergic neuronal damage .
loading...
    loading...
Cat. No.: HY-132392S
CAS No.: 53587-29-4
Purity:  98.80%
L-DOPA-2,5,6-d3 is the deuterium labeled L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain .
loading...
    loading...
Cat. No.: HY-N0304S
CAS No.: 713140-75-1
Synonyms: LevoDOPA-d6; 3,4-Dihydroxyphenylalanine-d6
L-DOPA-d6 is the deuterium labeled L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease .
loading...
    loading...
Cat. No.: HY-116016
CAS No.: 37178-37-3
Purity:  99.00%
Synonyms: L-DOPA ethyl ester; LevoDOPA ethyl ester
Research Areas:  

Neurological Disease

Etilevodopa (L-Dopa ethyl ester), an ethyl-ester proagent of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable proagent as it facilitates CNS penetration and delivers dopamine .
loading...
    loading...
Cat. No.: HY-113468AS
CAS No.: 586954-09-8
Purity:  ≥99.0%
Synonyms: 3-Methoxy-L-tyrosine-d3; 3-O-Methyl-L-DOPA-d3
3-O-Methyldopa-d3 (3-Methoxy-L-tyrosine-d3) is deuterium labeled 3-O-Methyldopa (HY-113468A). 3-O-Methyldopa (3-Methoxy-L-tyrosine) is a metabolite of L-DOPA (HY-N0304) that can cross the blood-brain barrier (BBB). 3-O-Methyldopa inhibits the astrocyte-mediated protective effect of L-DOPA (HY-N0304) on dopaminergic neurons. In addition, 3-O-Methyldopa has certain antidepressant and neuroprotective activities. 3-O-Methyldopa can be used in the research of nervous system diseases such as depression and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-109131
CAS No.: 1907685-81-7
Purity:  95.91%
Synonyms: ABBV-951; CarbiDOPA 4′-monophosphate
Foscarbidopa (ABBV-951; Carbidopa 4′-monophosphate) is an inhibitory prodrug targeting peripheral aromatic L-amino acid decarboxylase. Foscarbidopa is hydrolyzed into Carbidopa (HY-B0311) by phosphatases in vivo to suppress peripheral metabolism of levodopa and elevate brain delivery of levodopa. Foscarbidopa can be used for the research of Parkinson’s disease and advanced Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-106405
CAS No.: 274925-86-9
Purity:  99.89%
Synonyms: BIA 3-202
Target:  

COMT

Research Areas:  

Metabolic Disease

Nebicapone (BIA 3-202), a reversible catechol-O-methyltransferase (COMT) inhibitor, is mainly metabolized by glucuronidation. Nebicapone is mainly peripherally acting inhibitor that decreases the biotransformation of L-DOPA to 3-O-methyl-DOPA by inhibition of COMT, and it is potential for the treatment of Parkinson's disease .
loading...
    loading...
Cat. No.: HY-141647
CAS No.: 1614253-58-5
Research Areas:  

Others

18F-Labeled L-dopa precursor is a precursor for synthesis of 18F-labeled L-dopa .
loading...
    loading...
Cat. No.: HY-132404S
CAS No.: 1219173-95-1
Purity:  98.73%
(rac)-3-O-Methyl DOPA-d3 is the deuterium labeled (rac)-3-O-Methyl DOPA .
loading...
    loading...
Cat. No.: HY-124501
CAS No.: 1814-64-8
Purity:  99.24%
Synonyms: p-NH2-PE-TFMPP
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

LY 165163 is a potent 5-HT presynaptic receptor agonist. LY 165163 significantly decreases 5-HTP accumulation and increases DOPA accumulation in the cortex and striatum .
loading...
    loading...
Cat. No.: HY-W037976
CAS No.: 25369-78-2
Synonyms: 5-Chloro-2-mercaptobenzimidazole
Research Areas:  

Cancer

Tyrosinase-IN-22 (compound 4) is an inhibitor of tyrosinase substrates (L-tyrosine and L-dopa) with IC50s of 60 nM and 30 nM, respectively. Tyrosinase-IN-22 also shows potent antioxidant and anti-melanogenic properties, thus can be used for relevant researches .
loading...
    loading...
Cat. No.: HY-W152604
CAS No.: 5845-67-0
Synonyms: Cyclo(leu-gly)
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity. Cyclo(glycyl-L-leucyl) inhibits the development of Morphine induced pain relief as well as dopamine receptor supersensitivity in rats. Cyclo(glycyl-L-leucyl) has the potential for the prevention of tardive and/or L-DOPA (HY-N0304)-induced dyskinesias .
loading...
    loading...
Cat. No.: HY-113468R
CAS No.: 7636-26-2
Synonyms: 3-Methoxytyrosine (Standard)
3-O-Methyl-DL-DOPA (Standard) is the analytical standard of 3-O-Methyl-DL-DOPA. This product is intended for research and analytical applications. 3-O-Methyl-DL-DOPA is an endogenous metabolite present in Cerebrospinal_Fluid that can be used for the research of Epilepsy, Purine Nucleoside Phosphorylase Deficiency and Aromatic L Amino Acid Decarboxylase Deficiency [4].
loading...
    loading...
Cat. No.: HY-N0304S1
CAS No.: 201417-12-1
Synonyms: LevoDOPA-13C6; 3,4-Dihydroxyphenylalanine-13C6
L-DOPA- 13C6 is the 13C-labled L-DOPA . L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease .
loading...
    loading...